Link to this page
Medical Subject Headings
Preferred Name | Morphine | |
Synonyms |
MS Contin SDZ 202250 SDZ202250 SDZ 202 250 SDZ202 250 Duramorph Sulfate, Morphine Chloride, Morphine Contin, MS Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)- Morphine Chloride Morphine Sulfate (2:1), Anhydrous SDZ202-250 Oramorph SR Morphine Sulfate Morphia Morphine Sulfate (2:1), Pentahydrate SDZ 202-250 |
|
Definitions |
The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. |
|
ID |
http://purl.bioontology.org/ontology/MESH/D009020 |
|
altLabel |
MS Contin SDZ 202250 SDZ202250 SDZ 202 250 SDZ202 250 Duramorph Sulfate, Morphine Chloride, Morphine Contin, MS Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)- Morphine Chloride Morphine Sulfate (2:1), Anhydrous SDZ202-250 Oramorph SR Morphine Sulfate Morphia Morphine Sulfate (2:1), Pentahydrate SDZ 202-250
|
|
AN |
/analogs = MORPHINE DERIVATIVES
|
|
AQL |
AD AE AG AI AN BI BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
cui |
C0700787 C0949362 C0026549 C0949361 C0700703 C0700785 C0700786 C0066814 C0026551
|
|
DC |
1
|
|
definition |
The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.
|
|
DX |
19600101
|
|
EC |
analogs & derivatives:Morphine Derivatives
|
|
FX |
D011957
|
|
HN |
MORPHINE SULFATE was (NM) 1980-96
|
|
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
Inverse of RB |
64-31-3 X3P646A2J0 6211-15-0 0 76I7G6D29C
|
|
Inverse of RO | ||
isa | ||
LT |
TRD
|
|
Machine permutation |
MORPHINE SULFATE was indexed under MORPHINE 1980-96
|
|
Mapped from |
http://purl.bioontology.org/ontology/MESH/C550436 http://purl.bioontology.org/ontology/MESH/C030674 http://purl.bioontology.org/ontology/MESH/C020234 http://purl.bioontology.org/ontology/MESH/C041810 http://purl.bioontology.org/ontology/MESH/C402830 http://purl.bioontology.org/ontology/MESH/C034701 http://purl.bioontology.org/ontology/MESH/C097397 http://purl.bioontology.org/ontology/MESH/C493775 http://purl.bioontology.org/ontology/MESH/C468112 http://purl.bioontology.org/ontology/MESH/C006992 http://purl.bioontology.org/ontology/MESH/C576454 |
|
MDA |
19990101
|
|
MMR |
20160531
|
|
MN |
D03.633.400.686.607.587 D03.605.497.607.587 D04.615.723.795.576.571 D03.132.577.249.562.571
|
|
notation |
D009020
|
|
PA |
D000701 D009294
|
|
prefLabel |
Morphine
|
|
RR |
6211-15-0 (sulfate (2:1) (salt) pentahydrate) 57-27-2 (Morphine) X3P646A2J0 64-31-3 (sulfate (2:1) (salt) anhydrous)
|
|
TERMUI |
T026961 T026958 T026955 T360239 T026959 T026960 T026963 T026956 T026962 T026957 T360240
|
|
TH |
NLM (1997) NLM (1999) FDA SRS (2014) UNK (19XX) NLM (1998) USP (19XX) BAN (19XX)
|
|
tui |
T109 T121
|
|
subClassOf |
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |